Skip to content
Forcyte Biotechnologies, Inc

the function-first biology company

Menu
  • Company
    • VISION
    • ABOUT
    • TEAM
    • NEWS
    • CONTACT
  • Platform
    • FLECS TECHNOLOGY
    • PUBLICATIONS
  • Mechanomics
    • MECHANOMIC DISEASES
    • PIPELINE

Month: March 2018

Uncategorized

Forcyte is hiring! Seeking Associate Bioengineer to jumpstart operations in the LA-area

We are seeking a razor-sharp and self-driven ‘A-player’ trained in and stimulated by biotechnology to join the founding team and lead operations in our LA Biomed location! Great opportunity to …

Uncategorized

The team’s flagship work on the FLECS platform published in Nature Biomedical Engineering

>3 years of work and development in the Di Carlo Lab has led to a thorough publication describing the broad capabilities and use-cases for the FLECS platform. On February 8, …

Uncategorized

Dr. Pushkarsky’s perspective describing FLECS is published in ADT

Dr. Pushkarsky presented the team’s overall work on FLECS Technology at the annual SBI2 meeting in San Diego back in September 2017. He was happy to have been awarded the …

Recent Posts

  • Forcyte Bio Secures New Funding From Y Combinator & Others, Bringing Total to >$5.7 Million
  • Forcyte awarded Phase 2 SBIR by NIH / NCATS to develop pseudo-3D contractile “tissuoid” assay enabling study of coordinated cell contractions and tachyphylaxis
  • New App Note covering FLECS Technology in collaboration with Molecular Devices is now available:
  • Forcyte’s Cardiac Tissuoid assay is now available
  • Forcyte Bio to participate in Innovation AveNEW for Startups Showcase at SLAS 2019

Recent Comments

    Archives

    • June 2022
    • September 2019
    • May 2019
    • January 2019
    • July 2018
    • April 2018
    • March 2018
    • November 2017

    Categories

    • Conferences
    • Funding
    • New Materials
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Copyright © 2017 Forcyte Biotechnologies, Inc